Form 4 Filing for ADIAL PHARMACEUTICALS, INC.

This filing details a Form 4 filed by Kevin Schuyler, a director at ADIAL PHARMACEUTICALS, INC. On April 7, 2026, Mr. Schuyler acquired 9,185 shares of common stock through a grant of restricted stock, which vest in full on the earlier of the one-year anniversary of the grant date or a Change of Control, subject to continued service. The transaction code was 'A' for acquisition, with a price per share of $0.0. Following this transaction, Mr. Schuyler has 9,213 shares beneficially owned. The filing also notes indirect ownership of 4 shares held by his wife, Carolyn M. Schuyler, and 230 shares held by MVA 151 Investors, LLC, over which Mr. Schuyler has control.